TY - JOUR
T1 - Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets
AU - Lohmann, Christine
AU - Schäfer, Nicola
AU - von Lukowicz, Tobias
AU - Sokrates Stein, M. A.
AU - Borén, Jan
AU - Rütti, Sabine
AU - Wahli, Walter
AU - Donath, Marc Y.
AU - Lüscher, Thomas F.
AU - Matter, Christian M.
N1 - Funding Information:
Funding: This work was funded in part by grants from the Swiss National Science Foundation 31-114094/1 (CMM) and 3100-068118 (TFL), the University Research Priority Program Integrative Human Physiology at the University of Zurich (NS, TvL, MASS, SR, MYD, TFL, CMM) and by unrestricted grants from the MERCATOR Foundation and a strategic alliance with Pfizer Inc., New York.
PY - 2009/12
Y1 - 2009/12
N2 - Objective: Atherosclerosis is a chronic inflammatory disease of major conduit arteries. Similarly, obesity and type 2 diabetes mellitus are associated with accumulation of macrophages in visceral white adipose tissue and pancreatic islets. Our goal was to characterize systemic inflammation in atherosclerosis with hypercholesterolemia, but without obesity. Methods and results: We compared 22-week-old apolipoprotein E knockout (ApoE-/-) with wild-type mice kept for 14 weeks on a high cholesterol (1.25%) diet (CD, n = 8) and 8-week-old ApoE-/- with wild-type mice kept on a normal diet (ND, n = 8). Hypercholesterolemic, atherosclerotic ApoE-/- mice on CD exhibited increased macrophages and T-cells in plaques and periadventitial adipose tissue that revealed elevated expression of MIP-1α, IL-1β, IL-1 receptor, and IL-6. Mesenteric adipose tissue and pancreatic islets in ApoE-/- mice showed increased macrophages. Expression of IL-1β was enhanced in mesenteric adipose tissue of ApoE-/- mice on CD. Furthermore, these mice exhibited steatohepatitis with macrophage and T-cell infiltrations as well as increased MIP-1α and IL-1 receptor expression. Blood glucose, insulin and total body weight did not differ between the groups. Conclusions: In hypercholesterolemic lean ApoE-/- mice, inflammation extends beyond atherosclerotic plaques to the periadventitial and visceral adipose tissue, liver, and pancreatic islets without affecting glucose homeostasis.
AB - Objective: Atherosclerosis is a chronic inflammatory disease of major conduit arteries. Similarly, obesity and type 2 diabetes mellitus are associated with accumulation of macrophages in visceral white adipose tissue and pancreatic islets. Our goal was to characterize systemic inflammation in atherosclerosis with hypercholesterolemia, but without obesity. Methods and results: We compared 22-week-old apolipoprotein E knockout (ApoE-/-) with wild-type mice kept for 14 weeks on a high cholesterol (1.25%) diet (CD, n = 8) and 8-week-old ApoE-/- with wild-type mice kept on a normal diet (ND, n = 8). Hypercholesterolemic, atherosclerotic ApoE-/- mice on CD exhibited increased macrophages and T-cells in plaques and periadventitial adipose tissue that revealed elevated expression of MIP-1α, IL-1β, IL-1 receptor, and IL-6. Mesenteric adipose tissue and pancreatic islets in ApoE-/- mice showed increased macrophages. Expression of IL-1β was enhanced in mesenteric adipose tissue of ApoE-/- mice on CD. Furthermore, these mice exhibited steatohepatitis with macrophage and T-cell infiltrations as well as increased MIP-1α and IL-1 receptor expression. Blood glucose, insulin and total body weight did not differ between the groups. Conclusions: In hypercholesterolemic lean ApoE-/- mice, inflammation extends beyond atherosclerotic plaques to the periadventitial and visceral adipose tissue, liver, and pancreatic islets without affecting glucose homeostasis.
KW - Adipose tissue
KW - Atherosclerosis
KW - Hypercholesterolemia
KW - Macrophages
KW - Pancreatic islets
UR - http://www.scopus.com/inward/record.url?scp=70349554744&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2009.05.004
DO - 10.1016/j.atherosclerosis.2009.05.004
M3 - Article
C2 - 19481752
AN - SCOPUS:70349554744
SN - 0021-9150
VL - 207
SP - 360
EP - 367
JO - Atherosclerosis
JF - Atherosclerosis
IS - 2
ER -